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!!I~.,,, .. ;, ... ~ Importance of aflatoxins 
Aspergil/us Aflatoxin Bl 
Susceptible crops 
Occurrence 
40% of commodities in 
local markets exceed ML 
Maize, groundnuts, sorghum, 
cottonseed, chili, millet, figs, 
melon seed, ginger, sesame, 
cassava, almond, pistachio ... 
GrO<Jndnut exports 
in metric tons 
99.59% 
decrease 
51,450 48.23% JI ~~rease 
Biocontrol is a simple field intervention that effectively reduces 
aflatoxin contamination from farms until consumption 
!!I~.,,, .. 1, ... ~ Proof of Conce t 
• 32 agribusinesses 
• 49,500 farmers 
• 63,000 ha maize grown 
• 600 tons Aflasafe 
purch Grain lots (n = 2,362) with 
aflatoxin concentration % 
194,310 tons of grains 
harvested 
• 57°/o aggregated for sale 
• 27% consumed at ho ~ -
• 16% sold in local mar 
Productivity: 3.1 
tons/ha compared to 





• 10. 7% premium in 
the market over 
normal maize 
• $1.491 million in net 
earning from 
. premium 
\\TA c~ C · 1 · t· P th 
... .,.. :- .. ~."~ .. .Bl ommerc1a 1za 10n a • iTTCI flasafe 
1· Design of 
Commerdallzatlon 
Strateay 
- Complete Market analysis 
- Complete manufactul'iing I 
distribution feasibility studies 
• Identify enabling 
interventions 
- Sequence of interventions 
- Develop long list of 
investors 
YEARl 
2- Investors Mobilization 
and selection 
- Organize Investors Forum 
- Call for Expression of Interest 
- Conduct Investor due diligence 
- Develop short list of investors 
- Facilitate Business plan 
development and submission 
YEAR 2-3 
3- Implementation of the Strategy and investor Business 
plan 
- Negotiate binding commer,cfal agreements 
- Finalize Technology Transfer and Licensing Agreement (TTLA) 
- Support last mile distribution and testing solutions 
- Prepare and share product and education materials 
- Demonstrat! the effectiveness of the product 
- Organize trainings on the use of the product 
- Monitor progress 
- Share best practices and lessons learned with investors 
- Adjust country and portfolio strategies as necessary to achieve 
targets 
Cross-cutting: Awareness raising+ Advocacv for regu lations enforcement + Strat egic oartnershios wit h downstream actors 
aiTTC flasafe 
Safer food in Africa 
l *I SENEGAL 
Aflasafe SN01 launched Mar 2017 
Manufacturer /Distributor: BAMT AARE • --------, 
Distribution points: Tanbacounda, Katrine, 
Kaolack, Sedhiou and Fatick 
Aflasafe-protected hectares: 24,800 * 
THE GAMBIA 
Aflasafe SN01 launched Mar 2017 
Manufacturer/Distributor. BAMTMRE • 
• Af/asafe-protected hectares: 11 ,000 * 
Distribution points: Banjul, North Bank, 
Central River, West Coast Lower River Region 
= GHANA 
Aflasafe GH02 launched June 2018 
• Distributor: Macrofertil Ghana Limited 
• Distribution points: Accra, Tamale 
Af/asafe-protected hectares: 2,000* 
- Aflasafe commercialised 
Aflasafe product development 
~ Allasale factory 





Aflatoxins test results were below 4 parts per billion in all commercialisation countries 
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AFLASAFE TECHNOLOGY TRANSFER AND 
COMMERCIALISATION INITIATIVE (ADC) 
---------• 
• BURKINA FASO 
Aflasafe BF01 launched Jun 2018 
Distributor: Elephant Vert 
Distribution points: Bobo Dioulasso, 
Ouagadougou 
Aflasafe-protected hectares: 1,000 * 
--------• I I NIGERIA 
2013: Aflasafe TM commercialisation 
begins 
• Distributor: Harvestfield Industries Ltd 
Distribution points: Ekiti. Niger, Ondo, 
Abuja FCT, Osun, Kano, 
Oyo, Jigawa, Ogun, Kaduna, Edo, 
Katsina, Anambra, Zamfara, Imo, 
Sokoto, Kwara, Gombe, Kebbi. 
Bauchi 
Aflasafe-protected hectares: 92,400 * 
· • = KENYA 
I\TA~ 
~ -
Aflasafe KE01 launched Oct 2016 
• Manufacturer/Distributor: KALRO 
• Distribution point: Machakos 




,~T~~ .. ~ WHAT HAVE WE LEARNED? 
- This "Invisible problem" requires significant investment on public awareness 
and the enforcement of appropriate policies 
- The proof of concept in one country is essential but not sufficient to 
demonstrate the value of the product in all countries. 
- Timing of the investors forum: The demonstration at national level and the 
development of the Business cases earlier in year 1 may positively affect the 
success of investors mobilization 
- Ownership of the Business planning by the investor: From the strategy to the 
Business plan 
QUESTIONS? 
Management of the commercialization process: What is the right balance between the 
Business Development and the scientific work? 
How should business development approach differ between publicly funded innovations 
with public health benefits and privately funded innovations? 
What kind of institutional set up is required to sustain the gains and expand to other 
products? 
